BGLC logo

BioNexus Gene Lab (BGLC) Company Overview

Profile

Full Name:

BioNexus Gene Lab Corp.

Sector:

Basic Materials

Industry:

Specialty Chemicals

Country:

Malaysia

IPO:

January 8, 2021

Indexes:

Not included

Website:

http://www.bionexusgenelab.com

Description:

BGLC (BioNexus Gene Lab) specializes in biotechnology and genetic research. They focus on developing innovative solutions for healthcare, agriculture, and environmental sustainability. By harnessing advanced genetic technologies, BGLC aims to improve health outcomes and enhance crop productivity, contributing to a better future for society.

Key Details

Price

$0.38

Market Cap

$6.79 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$9.77 M(-10.60% YoY)

Annual EPS

-$0.18(-297.83% YoY)

PE Ratio

-

Annual ROE

-32.21%

Annual Debt To Equity

0.00

Beta

0.23

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Nov 15, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 20, 2023

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with BGLC included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
Basic materials sector
Stocks below SMA 200
Best performing stocks last 3 months
Stocks above SMA 50
All stocks
NASDAQ Listed Companies
Biggest stock gainers today
Best performing stocks YTD

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.38
BGLC price is $0.38

Price All-time High

$5.95
BGLC price is currently -93.65% below its historical high of $5.95

Price Analysts Target

-
BGLC price consensus analysts' forecast is unknown

Price Most Recent Change

+13.82%
BGLC price was up +13.82% on Mar 7, 2025

Price YTD Change

+55.53%
BGLC price is up +55.53% since January 1st

Price 3-Year Change

-79.89%
BGLC price is down -79.89% over the past 3 years

Market cap

Market Cap

$6.79 M
BGLC market capitalization is $6.79 million

Market Cap 3-Year Change

-74.67%
BGLC market capitalization is down -74.67% over the past 3 years

Market Cap All-time High

$86.14 M
BGLC market capitalization is currently -92.11% below its historical high of $86.14 million

Market Cap Sector Rank

4.48%
BGLC market capitalization is higher than 4.48% of companies in Basic Materials sector

Technical

Beta

0.23
BGLC beta is 0.23

200-day SMA

$0.40
BGLC price is currently -5.31% below its 200-day simple moving average

14-day RSI

54.62
BGLC 14-day relative strength index is 54.62

30-day Relative Volume

3.17
BGLC 30-day relative volume is 3.17

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$9.77 M
BGLC annual revenue is $9.77 million

Annual Revenue Analysts Estimate

-
BGLC annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-10.6%
BGLC annual revenue is down -10.6% year-on-year

Annual Revenue Sector Rank

8.93%
BGLC annual revenue is higher than 8.93% of companies in Basic Materials sector

Profit

Annual Gross Profit

$1.33 M
BGLC annual gross profit is $1.33 million

Annual Gross Margin

13.61%
BGLC annual gross profit margin is 13.61%

Annual Operating Profit

-$2.59 M
BGLC annual operating income is -$2.59 million

Annual Operating Margin

-26.54%
BGLC annual operating profit margin is -26.54%

Annual Net Income

-$2.63 M
BGLC annual net profit is -$2.63 million

Annual Net Margin

-26.91%
BGLC annual net profit margin is -26.91%

EPS

Annual EPS

-$0.18
BGLC annual earnings per share is -$0.18

Annual EPS Analysts Estimate

-
BGLC annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-297.83%
BGLC annual earnings per share is down -297.83% year-on-year

Annual EPS Sector Rank

33.33%
BGLC annual earnings per share is higher than 33.33% of companies in Basic Materials sector

ROA & ROE

Annual ROA

-26.11%
BGLC annual return on assets is -26.11%

Annual ROE

-32.21%
BGLC annual return on equity is -32.21%

EBIT & EBITDA

Annual EBIT

-$2.59 M
BGLC annual earnings before interest & taxes is -$2.59 million

Annual EBITDA

-$2.49 M
BGLC annual EBITDA is -$2.49 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
BGLC price to earnings ratio value is unknown

PE Ratio Sector Rank

-
BGLC price to earnings ratio is unknown

PB Ratio

PB Ratio

0.72
BGLC price to book ratio is 0.72

PB Ratio Sector Rank

23.88%
BGLC price to book ratio is higher than 23.88% of companies in Basic Materials sector

PS Ratio

PS Ratio

0.73
BGLC price to sales ratio is 0.73

PS Ratio Sector Rank

31.53%
BGLC price to sales ratio is higher than 31.53% of companies in Basic Materials sector

Enterprise value

Enterprise Value

$2.88 M
BGLC enterprise value is $2.88 million

Enterprise Value Sector Rank

2.26%
BGLC enterprise value is higher than 2.26% of companies in Basic Materials sector

EV/EBITDA

EV/EBITDA

-3.79
BGLC EV/EBITDA is -3.79

EV/EBITDA Sector Rank

23.27%
BGLC EV/EBITDA is higher than 23.27% of companies in Basic Materials sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.93
BGLC annual current ratio is 4.93

Annual Quick Ratio

4.24
BGLC annual quick ratio is 4.24

Leverage

Annual Debt To Equity

0.00
BGLC annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-186.59
BGLC annual interest coverage ratio is -186.59

Risk & Stability

Piotroski F-Score

0
BGLC piotroski f-score is 0

Altman Z-Score

2.90
BGLC altman z-score is 2.90

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$11.40 M
BGLC annual total assets is $11.40 million

Annual Non Current Assets

$3.35 M
BGLC annual long term assets is $3.35 million

Annual Current Assets

$8.05 M
BGLC annual total current assets is $8.05 million

Annual Cash & Cash Equivalents

$5.93 M
BGLC annual cash & cash equivalents is $5.93 million

Equity

Annual Book Value

$9.66 M
BGLC annual book value is $9.66 million

Annual Working Capital

$6.42 M
BGLC annual working capital is $6.42 million

Liabilities

Annual Total Liabilities

$1.74 M
BGLC annual total liabilities is $1.74 million

Annual Total Long Term Liabilities

$111.00 K
BGLC annual total long term liabilities is $111.00 thousand

Annual Current Liabilities

$1.63 M
BGLC annual total current liabilities is $1.63 million

Annual Accounts Payable

$1.40 M
BGLC annual accounts payable is $1.40 million

Debt

Annual Total Debt

$133.40 K
BGLC annual total debt is $133.40 thousand

Annual Total Debt 1-Year Change

+134.86%
BGLC annual total debt is up +134.86% year-on-year

Annual Long Term Debt

$98.80 K
BGLC annual long term debt is $98.80 thousand

Annual Short Term Debt

$34.60 K
BGLC annual short term debt is $34.60 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$12.36 M
BGLC annual total expenses is $12.36 million

Annual Operating Expenses

$3.92 M
BGLC annual total operating expenses is $3.92 million

Annual Cost Of Goods Sold

$8.44 M
BGLC annual cost of goods sold is $8.44 million

Annual SGA

$4.41 M
BGLC annual SGA is $4.41 million

Annual D&A

$108.40 K
BGLC annual depreciation & amortization is $108.40 thousand

Annual Interest Expense

$13.90 K
BGLC annual interest expense is $13.90 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$1.30 M
BGLC annual cash flow from operations is -$1.30 million

Annual CFO 1-Year Change

-335.88%
BGLC annual cash flow from operations is down -335.88% year-on-year

Annual CFI

-$382.60 K
BGLC annual cash flow from investing activities is -$382.60 thousand

Annual CFI 1-Year Change

+15.07%
BGLC annual cash flow from investing activities is up +15.07% year-on-year

Annual CFF

$5.75 M
BGLC annual cash flow from financing activities is $5.75 million

Annual CFF 1-Year Change

+5218.21%
BGLC annual cash flow from financing activities is up +5218.21% year-on-year

Free CashFlow

Annual FCF

-$1.45 M
BGLC annual free cash flow is -$1.45 million

Annual FCF 1-Year Change

-391.54%
BGLC annual free cash flow is down -391.54% year-on-year

CAPEX

Annual CAPEX

$149.40 K
BGLC annual capital expenditures is $149.40 thousand

Annual CAPEX 1-Year Change

+175.65%
BGLC annual capital expenditures is up +175.65% year-on-year

Institutional Ownership

Similar stocks

BHIL logo
Benson Hill (BHIL)
ZKIN logo
ZK International Group Co (ZKIN)
FMST logo
Foremost Lithium Resource & Technology (FMST)
CRKN logo
Crown ElectroKinetics (CRKN)
GURE logo
Gulf Resources (GURE)
OMEX logo
Odyssey Marine Exploration (OMEX)
BON logo
Bon Natural Life Limited (BON)
ITP logo
IT Tech Packaging (ITP)
NITO logo
N2OFF (NITO)

FAQ

  • What is the ticker symbol for BioNexus Gene Lab?
  • Does BioNexus Gene Lab pay dividends?
  • What sector is BioNexus Gene Lab in?
  • What industry is BioNexus Gene Lab in?
  • What country is BioNexus Gene Lab based in?
  • When did BioNexus Gene Lab go public?
  • Is BioNexus Gene Lab in the S&P 500?
  • Is BioNexus Gene Lab in the NASDAQ 100?
  • Is BioNexus Gene Lab in the Dow Jones?
  • When was BioNexus Gene Lab's last earnings report?
  • When does BioNexus Gene Lab report earnings?

What is the ticker symbol for BioNexus Gene Lab?

The ticker symbol for BioNexus Gene Lab is NASDAQ:BGLC

Does BioNexus Gene Lab pay dividends?

No, BioNexus Gene Lab does not pay dividends

What sector is BioNexus Gene Lab in?

BioNexus Gene Lab is in the Basic Materials sector

What industry is BioNexus Gene Lab in?

BioNexus Gene Lab is in the Specialty Chemicals industry

What country is BioNexus Gene Lab based in?

BioNexus Gene Lab is headquartered in Malaysia

When did BioNexus Gene Lab go public?

BioNexus Gene Lab's initial public offering (IPO) was on January 8, 2021

Is BioNexus Gene Lab in the S&P 500?

No, BioNexus Gene Lab is not included in the S&P 500 index

Is BioNexus Gene Lab in the NASDAQ 100?

No, BioNexus Gene Lab is not included in the NASDAQ 100 index

Is BioNexus Gene Lab in the Dow Jones?

No, BioNexus Gene Lab is not included in the Dow Jones index

When was BioNexus Gene Lab's last earnings report?

BioNexus Gene Lab's most recent earnings report was on Nov 15, 2024

When does BioNexus Gene Lab report earnings?

The next expected earnings date for BioNexus Gene Lab is May 15, 2025